Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 25.70
-0.30 (-1.15%)
At close: Jan 9, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 148.23 million as of January 9, 2026. Its market cap has decreased by -0.71% in one year.
Market Cap
148.23M
Enterprise Value
295.74M
Revenue
839.38K
Ranking
n/a
PE Ratio
5.66
Stock Price
25.70
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 148.23M, a decrease of -38.36%. That is a compound annual growth rate of -11.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 148.23M | 4.05% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 288.83B |
| Novartis AG | 217.97B |
| Galderma Group AG | 39.22B |
| Lonza Group AG | 38.60B |
| Alcon | 31.75B |
| Sandoz Group AG | 26.13B |
| Straumann Holding AG | 15.89B |
| Sonova Holding AG | 12.52B |